Adtalem (NYSE:ATGE) Reports Upbeat Q4, Stock Soars
Vocational education company Adtalem Global Education (NYSE:ATGE) announced better-than-expected revenue in Q4 CY2024, with sales up 13.9% year on year to $447.7 million. The company’s full-year revenue guidance of $1.75 billion at the midpoint came in 1.5% above analysts’ estimates. Its non-GAAP profit of $1.81 per share was 32.1% above analysts’ consensus estimates.
Is now the time to buy Adtalem? Find out in our full research report .
Adtalem (ATGE) Q4 CY2024 Highlights:
"Growth with Purpose, our operational excellence strategy, has delivered exceptional results—marked by six straight quarters of enrollment growth—while advancing our mission to develop skilled healthcare professionals," said Steve Beard, chairman and chief executive officer, Adtalem Global Education.
Company Overview
Formerly known as DeVry Education Group, Adtalem Global Education (NYSE:ATGE) is a global provider of workforce solutions and educational services.
Education Services
A whole industry has emerged to address the problem of rising education costs, offering consumers alternatives to traditional education paths such as four-year colleges. These alternative paths, which may include online courses or flexible schedules, make education more accessible to those with work or child-rearing obligations. However, some have run into issues around the value of the degrees and certifications they provide and whether customers are getting a good deal. Those who don’t prove their value could struggle to retain students, or even worse, invite the heavy hand of regulation.
Sales Growth
A company’s long-term performance is an indicator of its overall quality. While any business can experience short-term success, top-performing ones enjoy sustained growth for years. Over the last five years, Adtalem grew its sales at a 10.1% annual rate. Although this growth is acceptable on an absolute basis, it fell short of our benchmark for the consumer discretionary sector, which enjoys a number of secular tailwinds.
Long-term growth is the most important, but within consumer discretionary, product cycles are short and revenue can be hit-driven due to rapidly changing trends and consumer preferences. Adtalem’s recent history shows its demand slowed as its annualized revenue growth of 8.2% over the last two years is below its five-year trend.
This quarter, Adtalem reported year-on-year revenue growth of 13.9%, and its $447.7 million of revenue exceeded Wall Street’s estimates by 4.7%.
Looking ahead, sell-side analysts expect revenue to grow 4.9% over the next 12 months, a deceleration versus the last two years. This projection is underwhelming and indicates its products and services will see some demand headwinds.
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link .
Cash Is King
If you’ve followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can’t use accounting profits to pay the bills.
Adtalem has shown impressive cash profitability, giving it the option to reinvest or return capital to investors. The company’s free cash flow margin averaged 13.4% over the last two years, better than the broader consumer discretionary sector.
Adtalem burned through $34.04 million of cash in Q4, equivalent to a negative 7.6% margin. The company’s cash burn was similar to its $22.38 million of lost cash in the same quarter last year. These numbers deviate from its longer-term margin, indicating it is a seasonal business that must build up inventory during certain quarters.
Over the next year, analysts predict Adtalem’s cash conversion will slightly improve. Their consensus estimates imply its free cash flow margin of 13.6% for the last 12 months will increase to 15.1%, it options for capital deployment (investments, share buybacks, etc.).
Key Takeaways from Adtalem’s Q4 Results
Revenue and EPS both beat convincingly in the quarter, which is a great start. Looking ahead, the company lifted its full-year revenue guidance, which is now above expectations. Full-year EPS also came in ahead. Zooming out, we think this was a very good quarter with some key areas of upside. The stock traded up 5.2% to $107.79 immediately after reporting.
Adtalem had an encouraging quarter, but one earnings result doesn’t necessarily make the stock a buy. Let’s see if this is a good investment. What happened in the latest quarter matters, but not as much as longer-term business quality and valuation, when deciding whether to invest in this stock. We cover that in our actionable full research report which you can read here, it’s free .